Natural IgM in immune equilibrium and harnessing their therapeutic potential.
about
Therapeutic implications of autoantibodies in rheumatoid arthritisEmerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune HomeostasisThe Homophilic Domain - An Immunological ArchetypeSLE-associated risk factors affect DC functionPolyreactive Antibodies: Function and QuantificationRegulatory functions of innate-like B cellsDeficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.Genome-wide scan identifies variant in TNFSF13 associated with serum IgM in a healthy Chinese male population.Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques.B-1a lymphocytes attenuate insulin resistanceGRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.Divergence of the response induced by xenogenic immunization in the sepsis survival of rats.Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG miceManipulation of the glycan-specific natural antibody repertoire for immunotherapyAntigen-driven induction of polyreactive IgM during intracellular bacterial infection.Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulationIncreased NHC Cells in the Peritoneal Cavity of Plasmacytoma Susceptible BALB/c Mouse.The role of B-1 cells in inflammationAltered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR).Characteristics of natural antibody-secreting cells.The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV.Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus.Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.A generalized quantitative antibody homeostasis model: antigen saturation, natural antibodies and a quantitative antibody network.Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.Fc-fusion proteins: new developments and future perspectives.Protective autoantibodies in the rheumatic diseases: lessons for therapy.Atypical Response of B-1 Cells to BCR Ligation: A Speculative Model.The protective role of immunoglobulins in fungal infections and inflammation.The human counterpart of mouse B-1 cells.What rheumatologists need to know about innate lymphocytes.Immunoglobulin M antibodies are not specific for serodiagnosis of human toxocariasis.Role of Natural IgM Autoantibodies (IgM-NAA) and IgM Anti-Leukocyte Antibodies (IgM-ALA) in Regulating Inflammation.Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature.Natural Antibodies: Next Steps Toward Translational Investigation.NKG2D Promotes B1a Cell Development and Protection against Bacterial Infection.Resiniferatoxin lowers TNF-α, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.Impact of Gastrointestinal Bacillus anthracis Infection on Hepatic B Cells.
P2860
Q26744033-68FF1E47-AFA2-41AD-BBA3-C7EB30508931Q26751003-E945CA0F-EBE1-440C-8FAF-EA03A5046F00Q26752282-3DA88AD9-655E-481D-BB57-9E2BA2A00935Q26774797-096309E1-C8F0-4D20-A85A-6639998276BFQ26999862-1999A7B1-9B9E-4FC6-93A2-B8523E8089F3Q27000352-2014190B-E431-4CEC-8BD8-204516D67AB0Q33729953-7C4D862A-2963-4271-A907-6D2174BB80B9Q34464703-8F4010AF-A6CA-41B1-831E-D2ED27BE9D71Q34881734-2A065453-977A-42B1-BA54-279890E5C203Q35004327-8316CE32-6575-4B99-85A2-8EDA5BF609D4Q35146307-1E97102C-A2FC-4087-9F31-2B85ED01EDD4Q35620023-6637BD81-A178-4CE2-ABC7-623CDC21B738Q35659085-12DBF27B-B3F8-4C26-BDC7-AF05534766E7Q35920081-4A4B35B2-F115-4101-AACA-15939FAD4044Q36106473-60C0216F-0A2A-4A0D-BD95-78D5E70666C5Q36158712-ED8535E6-A841-4D7A-97C5-A4416BF8E496Q36173295-EBDFC1B1-EE49-41AC-A54E-8A82BAA27D0BQ36296618-E1474F31-5959-4AF9-8A4E-F710CDC3A6C8Q36300670-E23A254A-C7A2-4B86-B96E-F67A8F135EFFQ36373409-0D9DC98E-BE2A-4604-9495-13A3FF5E91C0Q36822711-105EAC87-D6EC-4B5B-8ED3-791F5FB42C9EQ37039612-648DEA91-4565-4911-992F-1A33C5474798Q37499424-56AF9537-9690-48DF-AED5-22D8897272C3Q37556177-6AA85450-F401-42EA-BC95-F93CF65B6C40Q37677450-8D9D528D-D685-4828-A303-395DF48750A9Q37698474-42D77980-43AB-4072-80B8-E2B8069ED416Q38016455-2EDB4EF2-0164-43C6-9256-57778BBFB4E0Q38029985-943FD35E-9B56-4099-A9AF-43DB9775C605Q38090919-C696D82E-F536-46AF-BA53-B6059F8D2230Q38174880-7034FED3-368D-482E-9829-36FE7FE756F4Q38268922-41A5A2B5-C537-430F-A9A5-1B5BBC18DA8DQ38491162-9ED45BD4-39E9-4CA4-887F-B07FB23FB5E3Q38809547-E333314F-1B45-44F7-9F8E-ED7BDBBFD4ACQ39406512-09429213-DB77-4BC1-B34E-10D5EDEFE96AQ39429814-0CA42B11-98E8-46EA-8575-A0DB57587C41Q39449732-244B898A-91C2-474B-BFFC-FE5B4783CC94Q40151268-01CD940B-2EA0-46FA-81F4-B93382EBCE55Q40372110-3595D4F2-6D4D-4840-A075-ABEE5E8C36FFQ40506129-5C25C443-0CDF-49A6-9459-9F3ADE9420F2Q40506267-58CE2429-F1AE-4A47-8DBB-157CDC6693BF
P2860
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@ast
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@en
type
label
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@ast
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@en
prefLabel
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@ast
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@en
P2860
P356
P1476
Natural IgM in immune equilibrium and harnessing their therapeutic potential.
@en
P2093
Gregg J Silverman
P2860
P304
P356
10.4049/JIMMUNOL.1102107
P407
P577
2012-02-01T00:00:00Z